Tuo Wei

9.1k total citations · 8 hit papers
68 papers, 7.1k citations indexed

About

Tuo Wei is a scholar working on Molecular Biology, Biomaterials and Genetics. According to data from OpenAlex, Tuo Wei has authored 68 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 17 papers in Biomaterials and 11 papers in Genetics. Recurrent topics in Tuo Wei's work include RNA Interference and Gene Delivery (30 papers), Advanced biosensing and bioanalysis techniques (19 papers) and Nanoparticle-Based Drug Delivery (15 papers). Tuo Wei is often cited by papers focused on RNA Interference and Gene Delivery (30 papers), Advanced biosensing and bioanalysis techniques (19 papers) and Nanoparticle-Based Drug Delivery (15 papers). Tuo Wei collaborates with scholars based in China, United States and India. Tuo Wei's co-authors include Qiang Cheng, Daniel J. Siegwart, Lukas Farbiak, Lindsay T. Johnson, Sean A. Dilliard, Xing‐Jie Liang, Juan Liu, Huili Ma, Shuaidong Huo and Shubin Jin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.

In The Last Decade

Tuo Wei

60 papers receiving 7.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing

2020 1.6k citations Qiang Cheng, Tuo Wei et al. Nature Nanotechnology profile →
Size-Dependent Localization and Penetration of Ultrasmall Gold Nanoparticles in Cancer Cells, Multicellular Spheroids, and Tumors in Vivo

2012 743 citations Keyang Huang, Huili Ma et al. profile →
Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing

2021 483 citations Qiang Cheng, Tuo Wei et al. Nature Materials profile →
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing

2020 448 citations Tuo Wei, Qiang Cheng et al. Nature Communications profile →
Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery

2022 328 citations Yehui Sun, Xueliang Yu et al. profile →
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy

2023 266 citations Yan Zong, Yi Lin et al. Advanced Materials profile →
Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy

2022 183 citations Di Zhang, Xueliang Yu et al. Nature Nanotechnology profile →
Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models

2023 103 citations Tuo Wei, Yehui Sun et al. Nature Communications profile →

Peers

Countries citing papers authored by Tuo Wei

Since Specialization

Citations

This map shows the geographic impact of Tuo Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuo Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuo Wei more than expected).

Fields of papers citing papers by Tuo Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuo Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuo Wei. The network helps show where Tuo Wei may publish in the future.

Co-authorship network of co-authors of Tuo Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Tuo Wei. A scholar is included among the top collaborators of Tuo Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuo Wei. Tuo Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tissue-specific mRNA delivery and prime editing with peptide–ionizable lipid nanoparticles 2025 ·Nature Materials ·Yi Lin, (unknown), Zijin Luo, (unknown), Yan Zong, Hongyu Ren, Xiaolu Yu, Xiaoqiong Tan, Fan Liu, Tuo Wei, Qiang Cheng	4
2	CAR Macrophages Engineered In Vivo for Attenuating Myocardial Ischemia-Reperfusion Injury 2025 ·Circulation Research ·(unknown), Xintong You, (unknown), (unknown), Yanan Zhou, Yuhan Wang, (unknown), Yanan Meng, Xu Liu, Hao Zhang, Yujing Li, (unknown), (unknown), Pengfei Xu, (unknown), Yi Xiao, Zeyu Gao, Jian Zang, Tuo Wei, Moshi Song	5
3	Prime Editing: A Revolutionary Technology for Precise Treatment of Genetic Disorders 2025 ·Cell Proliferation ·(unknown), Yi Lin, Qiang Cheng, Tuo Wei	4
4	PHLDA1 Exacerbates Renal Ischemia-Reperfusion Injury by Suppressing Fatty Acid β-Oxidation via the PPARγ/CPT1a Pathway 2025 ·American Journal of Transplantation ·Zuoxing Niu, Bin Zheng, Tuo Wei, Guohong Deng, Mengjia Dou, Charles Z. Ding, (unknown)	0
5	Association of cardiovascular health with COPD (NHANES 2007-2020): mediating potential of lean body mass 2025 ·Frontiers in Endocrinology ·(unknown), Xiaoyu Chang, (unknown), (unknown), Ling Hou, (unknown), Tuo Wei, Guanghua Li	1
6	Intermittent heat stress facilitates the autophagy and apoptosis of the vascular endothelium in spontaneously hypertensive rats via the AMPK/mTOR/ULK1 pathway 2025 ·Microvascular Research ·(unknown), (unknown), Xiaomin Wu, Tuo Wei, (unknown), (unknown), Guanghua Li	0
7	Reduced Order Modeling of System by Dynamic Modal Decom-Position with Fractal Dimension Feature Embedding 2024 ·Fractal and Fractional ·Mingming Zhang, (unknown), (unknown), Tuo Wei, (unknown)	0
8	In situ production and secretion of proteins endow therapeutic benefit against psoriasiform dermatitis and melanoma 2023 ·Proceedings of the National Academy of Sciences ·Qiang Cheng, Lukas Farbiak, Amogh Vaidya, Erick Guerrero, Eunice E. Lee, (unknown), Xu Wang, Joshua Robinson, Sang M. Lee, Tuo Wei, (unknown), (unknown), Xizhen Lian, Richard C. Wang, Daniel J. Siegwart	11
9	Surface engineering of lipid nanoparticles: targeted nucleic acid delivery and beyond 2023 ·Biophysics Reports ·Yi Lin, Qiang Cheng, Tuo Wei	29
10	Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models breakdown → 2023 ·Nature Communications ·Tuo Wei, Yehui Sun, Qiang Cheng, Sumanta Chatterjee, Zachary Traylor, Lindsay T. Johnson, (unknown), Jialu Wang, Michael J. Torres, Xizhen Lian, Xu Wang, Yufen Xiao, Craig A. Hodges, Daniel J. Siegwart	103
11	Resveratrol-induced SIRT1 activation inhibits glycolysis-fueled angiogenesis under rheumatoid arthritis conditions independent of HIF-1α 2023 ·Inflammation Research ·(unknown), (unknown), (unknown), (unknown), Yan Li, (unknown), Tuo Wei, Opeyemi Joshua Olatunji, Jian Zuo, Jun Han	19
12	Gelatin/sodium alginate hydrogel-coated decellularized porcine coronary artery to construct bilayer tissue engineered blood vessels 2022 ·International Journal of Biological Macromolecules ·Jing Du, Xueyan Hu, Ya Su, Tuo Wei, Zeren Jiao, Tianqing Liu, Hong Wang, Yi Nie, Xiangqin Li, Kedong Song	31
13	Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy breakdown → 2022 ·Nature Nanotechnology ·Di Zhang, (unknown), Xueliang Yu, Tuo Wei, Lukas Farbiak, Lindsay T. Johnson, Alan Taylor, Jiazhu Xu, Yi Hong, Hao‐Jie Zhu, Daniel J. Siegwart	183
14	Polymer-tetrodotoxin conjugates to induce prolonged duration local anesthesia with minimal toxicity 2019 ·Nature Communications ·Chao Zhao, Andong Liu, Claudia M. Santamaria, (unknown), Tianjiao Ji, Tuo Wei, (unknown), (unknown), Manisha Mehta, Rong Yang, Daniel S. Kohane	68
15	Getting Drugs Across Biological Barriers 2017 ·Advanced Materials ·Rong Yang, Tuo Wei, Hannah Goldberg, Weiping Wang, Kathleen Cullion, Daniel S. Kohane	178
16	Light-Emitting Photon-Upconversion Nanoparticles in the Generation of Transdermal Reactive-Oxygen Species 2017 ·ACS Applied Materials & Interfaces ·Martín Prieto, Alina Y. Rwei, Teresa Alejo, Tuo Wei, (unknown), Gracia Mendoza, Víctor Sebastián, Daniel S. Kohane, Manuel Arruebo	18
17	Gene transfection efficacy and biocompatibility of polycation/DNA complexes coated with enzyme degradable PEGylated hyaluronic acid 2013 ·Biomaterials ·Wendi Zhang, Qiang Cheng, Shutao Guo, Daoshu Lin, Pingsheng Huang, Juan Liu, Tuo Wei, Liandong Deng, Zicai Liang, Xing‐Jie Liang, Anjie Dong	71
18	The effect of guanidinylation of PEGylated poly(2-aminoethyl methacrylate) on the systemic delivery of siRNA 2013 ·Biomaterials ·Qiang Cheng, Yuanyu Huang, Hua Zheng, Tuo Wei, Shuquan Zheng, Shuaidong Huo, Xiaoxia Wang, Quan Du, Xiao‐Ning Zhang, Hongyan Zhang, Xing‐Jie Liang, Chun Wang, Rupei Tang, Zicai Liang	42
19	Superior Penetration and Retention Behavior of 50 nm Gold Nanoparticles in Tumors 2012 ·Cancer Research ·Shuaidong Huo, Huili Ma, Keyang Huang, Juan Liu, Tuo Wei, Shubin Jin, Jinchao Zhang, Shengtai He, Xing‐Jie Liang	288
20	CO2 gas induced drug release from pH-sensitive liposome to circumvent doxorubicin resistant cells 2012 ·Chemical Communications ·Juan Liu, Huili Ma, Tuo Wei, Xing‐Jie Liang	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact